Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by ProfCorneliuson May 07, 2020 7:26pm

298 Views

Post# 31000653

RE:When do we realistically expect to see $20?

PuffnPass13 wrote:
Hey guys,

im not new to the industry and unfortunately I lost a lot of money in small players in the cannabis sector and with the remainder I've went all in on APHA!

I always knew APHA would be one of the top LPs but after seeing their Q3 I can't believe this is trading at only x2.5 f/e with market cap of 1.4 vs cgc at 8 so I know we have an undervalued stock.

the question is how long realistically do you guys think it will take for apha to be at $20 again? That would mean it would have a 5.6 billion market cap (still lower than cgc currently).

i know cgc and cronos have larger cash position than us but that's thanks to their corporate sponsorship, which both have mistimed getting into the industry and over-paying.

serious comments only no bs. Thanks

Fall 2021 IF Aphria doesn't get taken out first and there is a vaccine for COVID 19.

As I have stated earlier, there is a race.
Scientists need to create the vaccine before the virus mutates too much for the vaccine to be effective .Otherwise, we start all over again...

Prof